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Kingdom
Background: The timing of carotid endarterectomy (CEA) following thrombolysis for acute ischemic stroke remains
controversial. We have described our unit’s experience and performed a systematic review and pooled data synthesis of the
safety of CEA in this group of patients.
Methods: Retrospective analysis of patients who had undergone CEA following thrombolysis between 2010 and 2012 was
performed. A systematic review of the literature was also performed using PUBMED, EMBASE, and major conference
proceedings. The primary outcome measure was 30-day postoperative intracerebral hemorrhage (ICH) and ischemic
stroke. The secondary outcome measures were 30-day postoperative all-cause morbidity and mortality.
Results: Seven patients underwent CEA following thrombolysis with mean age6 standard deviation of 70.576 7.57. Five
were men and ﬁve had CEA under local anesthesia. CEA was performed in median of 7 days (range, 2-12) after onset of
stroke. Thirty-day morbidity was 14% (1/7) with one patient who experienced ICH postoperatively. There was no
mortality. Nine studies were identiﬁed for systemic review. Seventy patients were included in the pooled data synthesis.
One patient (1%) experienced postoperative ICH. When our series was included, the 30-day postoperative ICH was 3%
(2/77). The overall 30-day postoperative morbidity was 4% (3/77), and there was no mortality.
Conclusions: Despite slightly higher rates of postoperative hemorrhagic strokes than those in randomized trials,
CEA appears safe following thrombolysis for acute ischemic stroke. However, more data on the timing of surgery is
needed. (J Vasc Surg 2013;58:1671-7.)Carotid endarterectomy (CEA) is an established treat-
ment for symptomatic carotid stenosis, which accounts for
15%-20%of ischemic stroke. Large randomized control trials
and subsequent meta-analysis have demonstrated that CEA
conferred the greatest beneﬁt when operated within
2 weeks.1-3Although there have been continuous emerging
evidence on the timing and safety of CEA in patients with
stable and unstable ischemic stroke, there is little data
regarding the efﬁcacy of CEA following thrombolysis for
stroke.
Recombinant tissue plasminogen activator (rtPA) has
been licenced for use as a thrombolytic agent in patients
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cerebral hemorrhage (ICH), which is compounded by
effects on the coagulation pathway even after the clearance
of rtPA, the use of antiplatelet agents and potential reperfu-
sion injury with CEA.4
The contemporary evidence on the safety of CEA
following thrombolysis is limited to pilot study and case
series with small number of patients. The aims of this study
are to report the outcome of CEA following thrombolysis
at our institution and to perform a systematic review and
pooled data analysis of the literature.
METHODS
Single-center review
A retrospective review of two prospectively collected
databases (CEA and thrombolysis database) was performed
at the NottinghamUniversity Hospitals. Patients were iden-
tiﬁed by cross-referencing the CEA database and the throm-
bolysis database for stroke between July 2010 and May
2012. Only patients who were operated within 30 days
from the onset of stroke were included in the study. Data
collected include patient demographics, type of stroke
according to the Oxfordshire classiﬁcation of stroke,
National Institutes of Health Stroke Scale (NIHSS) score,
the degree of ipsilateral and contralateral stenosis, results of
computed tomography (CT) of the brain, timing of CEA,1671
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Rankin scale (mRS) on discharge.
Systematic thrombolysis with recombinant tPA was
given up to 4.5 hours from the onset of stroke, in accordance
to the national guidelines5 and randomized controlled
trials.6 All patients have had CT of the brain prior to and
24 hours after thrombolysis to exclude ICH. ICH is deﬁned
as any apparent extravascular blood in the brain or within the
cranium that was associated with clinical deterioration, as
deﬁned by an increase of four points or more in the score
on the NIHSS or that led to death and that was identiﬁed
as the predominant cause of the neurologic deterioration.6
The degree of carotid stenosis was then determined
by duplex ultrasound according to the North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
criteria,2 and patients were referred to the vascular unit if
the degree of carotid stenosis was signiﬁcant (>50%). Deci-
sion for surgery was made by the consultant vascular
surgeon on-call, and all patients were started on aspirin
preoperatively (300 mg of loading dose, followed by
75 mg daily). The patients did not receive any anticoagula-
tion prior to CEA. CEA was performed in the next avail-
able operating list following vascular referral. All patients
were operated on the ipsilateral symptomatic internal
carotid artery. Five patients were initially operated under
local anesthesia, and two patients had general anesthetic
with invasive blood pressure monitoring both intra- and
postoperatively (for at least 2 hours) to maintain an accept-
able range of blood pressure. All patients received between
3000-5000 units of heparin intraoperatively only depend-
ing on body weight. Patients were followed up at 6 weeks.
Systematic review
Search strategy. A literature reviewwas undertaken for
studies published between 1960 and August 2012 on the
safety of CEA following thrombolysis for acute ischemic
stroke. An electronic search on MEDLINE and EMBASE
was performed using prespeciﬁed keywords: “carotid endar-
terectomy thrombolysis,” “carotid intervention thromboly-
sis,” and “carotid surgery thrombolysis.” The reference list
of each article was also searched by hand. The electronic
search was supplemented by a hand-search of published
abstracts from meetings of the Vascular Society of Great
Britain and Ireland, the Society for Vascular Surgery, the
Association of Surgeons of Great Britain and Ireland, the
European Society for Vascular Surgery, European Stroke
Conference, World Stroke Congress, and International
Stroke Conference.
Selection criteria. We included only articles published
in English with data on patients who have had CEA
following an acute ischemic stroke with signiﬁcant carotid
stenosis, after either intravenous or intra-arterial throm-
bolysis. Articles published in non-English language, or
those on carotid thrombectomy or embolectomy and
intraoperative thrombolysis were excluded (Fig). Selection
of articles was performed independently by two of the
authors (Y.Y., N.A.), and the discrepancies were resolved
by consensus.Outcome measures. The primary outcome was the
incidence of 30-day postoperative ICH and ischemic
stroke. The secondary outcome was 30-day postoperative
all-cause morbidity and mortality.
Signiﬁcant carotid stenosis was deﬁned as ipsilateral
>50% stenosis as determined by ultrasound, CT, magnetic
resonance imaging (MRI), or cerebral angiography. Throm-
bolysis was deﬁned as administration of thrombolytic agent
within the time frame determined by local guidelines for
the treatment of acute ischemic stroke, following exclusion
of cerebral hemorrhage on brain imaging. Timing of CEA
was deﬁned as day(s) between onset of symptoms and
CEA. Postoperative stroke was deﬁned as new neurologic
deﬁcit lasting more than 24 hours postoperatively.
The data from eligible papers were abstracted in to
a Microsoft Excel spread sheet. In cases where data were
not available, the corresponding author was contacted by
e-mail for clariﬁcation and request of additional data. How-
ever, only limited number of authors responded to enquiry.
RESULTS
Single-center review
A total of 214 patients received intravenous thrombol-
ysis with alteplase between July 2010 and May 2012 for
acute ischemic stroke. However, data was only available
for 213 patients. The 30-day post-thrombolysis mortality
was 12% (26/213). All patients received CT of the brain,
of which 78% (167/213) had evidence of infarction.
Nine percent of patients (19/213) subsequently received
MRI of the brain (because of recurrent symptoms and
the absence on acute infarction on CT), and all had
evidence of infarction. On duplex ultrasound of the symp-
tomatic carotid artery, 67% (142/213) had insigniﬁcant
carotid stenosis, 6% (12/213) had occluded internal
carotid artery (ICA), and 9% (19/213) had signiﬁcant
carotid stenosis. Among these patients with signiﬁcant ipsi-
lateral carotid stenosis, eight (4%, ﬁve male, mean age
70.66 7) were referred to the vascular unit in Nottingham
and seven (ﬁve male, mean age 70.57 6 7.57) subse-
quently underwent CEA. One patient had a delayed CEA
71 days after the onset of index event because of acute
myocardial infarction shortly after ischemic stroke. We
have therefore excluded this patient from the analysis.
The rest of the 11 patients who had carotid stenosis
did not receive CEA because of complications post-
thrombolysis (one patient), refused surgery (one patient),
and unﬁt for surgery (six patients, admitted with disabling
stroke with unimproved neurologic status following system-
atic thrombolysis). None had further symptoms at median
follow-up of 24.5 months (range, 10-31). One died 10
months after index event because of pneumonia, distal
ICA stenosis (two patients), and referral to other vascular
unit for intervention (one patient). Demographics, neuro-
logic presentations, comorbidities, and risk factors are
shown in Table I.
The median NIHSS score before and after thromboly-
sis was 15 (range, 10-22) and 11 (range, 2-18). CT of the
Table I. Baseline characteristics on admission to stroke unit for patients who have subsequently undergone carotid
endarterectomy (CEA) following thrombolysis
Patient Age Sex
Type of
strokea BMI IHD HTN AF HCL DM
TIA/
stroke COPD Aspirin Clopidogrel Anti-BP Statin Warf Smoking
1 68 M R TAC 35 N N N N N N N N N N Y N Ex
2 75 F R PAC 34 N N N N N N N N N N Y N Ex
3 74 M R TAC 23 N N N N N Y N N N N Y N Ex
4 62 M R PAC 23 N Y N N N N N N N Y Y N N
5 66 F L LAC 40 N N N Y Y N Y Y N Y Y N Y
6 65 M L PAC 28 Y Y Y Y Y N N Y N Y Y N Ex
7 84 M L TAC 30 Y Y Y Y N N N Y N Y Y N N
AF, Atrial ﬁbrillation; anti-BP, antihypertensive; BMI, body mass index; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; Ex, ex-smoker;
HCL, hypercholesterolemia; HTN, hypertension; IHD, ischemic heart disease; L, left; LAC, lacunar syndrome; N, no; PAC, partial anterior circulation
syndrome; R, right; TAC, total anterior circulation syndrome; TIA/stroke, previous transient ischemic attack or stroke; Warf, warfarin; Y, yes.
aType of stroke ¼ stroke classiﬁcation according to the Oxfordshire classiﬁcation of stroke.
14 articles screened for abstract and 
language
4 articles excluded 
• 2 articles in non-English language 
• 1 article on intra-operative thrombolysis 
• 1 article on CEA and embolectomy
10 articles assessed in full-text for eligibility 1 article excluded 
• Carotid embolectomy post-thrombolysis
9 articles were included in quantitative 
analysis
286 articles identified through 
MEDLINE and EMBASE  
2 articles identified through 
conference proceedings
288 articles screened for title 274 articles excluded 
Fig. Preferred Reporting Items for Systematic Reviews andMeta-Analyses (PRISMA) ﬂow diagram for systematic review.
CEA, Carotid endarterectomy.
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small subacute infarction, one had no evidence of acute
infarction, and one had a small subacute infarction with
small patches of petechial hemorrhage. CEA was per-
formed on a median of 7 days (range, 2-12) from the onset
of symptoms by a consultant vascular surgeon. Five patients
were operated under local anesthesia, one under general
anesthesia, and one was converted from local to general
anesthesia because of agitation.
Of all patients who have subsequently received CEA,
one (14%, patient number 5, Table II) suffered postopera-
tive ICH on the same day following surgery. The patient
became hypertensive toward the end of CEA. This was
managed medically, and a subsequent CT head demon-
strated an ICH at the point of previous infarct suggestive
of a reperfusion injury. There was no 30-day postoperative
recurrent ischemic stroke, morbidity, or mortality. The
median mRS on discharge was 2 (range, 0-4).
Systematic review
A total of 14 articles were identiﬁed as potential source
of information on the safety of CEA following thrombolysisfor acute ischemic stroke. Four articles were excluded
during the screening for abstract and language. Two articles
were published in non-English language, one article per-
formed intraoperative thrombolysis, and one article per-
formed CEA and embolectomy in complete ICA
occlusion. After assessing the remaining nine articles in
full text, a further article was excluded for performing
carotid embolectomy post-thrombolysis. A total of nine
articles that consists of eight full text articles and one confer-
ence abstract were included in quantitative analysis. The
author of the conference proceeding7 has been contacted.
However, they did not publish their results. Seventy patients
were identiﬁed in nine studies7-15 (eight retrospective and
one prospective; Table III). A summary of systematic review
is presented in Table IV.
Preoperative management. In addition to the initial
diagnostic brain imaging, Leseche et al15 performed MRI
of the brain if the time from onset of the initial symptoms
was within 3 hours. Four studies9,12,13,15 reported the
NIHSS score on admission, one study14 reported the
median fall in NIHSS score 24 hours after thrombolysis
(7; range, 0-12), and none of the studies reported the
Table II. Operative data of patients who have undergone carotid endarterectomy (CEA) following thrombolysis for
acute ischemic stroke
Patient
NIHSS
prethrombolysis
NIHSS
post-
thrombolysis
Ipsilateral
stenosis, %
Contralateral
stenosis, %
Timing
of CEA,
day Anesthesia Shunt
Postop
ICH
mRS on
discharge
1 16 3 80%-99% <30 10 LA N N 0
2 15 12 50%-59% <30 11 LA N N 3
3 15 11 60%-69% <30 3 LA N N 0
4 11 2 60%-69% <30 7 LA N N 2
5 10 10 70%-79% 60-69 2 LA N Y 4
6 18 18 60%-69% <30 12 Convert Y N 2
7 22 16 60%-69% 80-95 7 GA Y N 3
Convert, Converted from local to general anesthesia; GA, general anesthesia; ICH, intracerebral hemorrhage; LA, local anesthesia; mRS, modiﬁed Rankin
scale; N, no; NIHSS, National Institutes of Health Stroke Scale; Y, yes.
Table III. Data of eight series included in pooled data analysis and systematic review
1st author,
year Study No. (M)
Mean age
(range)
NIHSS on
admissiona
Degree of
stenosis,% Thrombolysis
Timing of
CEA, daysa
Postop
morbidity
Postop
ICH mRSa
Endo, 19989 R 1 (1) 73 >24 NA IA 0 0 0 1 at 1 month
Eckstein, 199910 P 3 (2) 58 (41-75) NA >70 IV 14 (6-21) 0 0 1 (0-3) at 6
months
Uno, 200111 R 4 (4) 69 (64-77) NA NA IA 13.5 (1-54) 0 0 NA
McPherson,
200112
R 5 (4) 59 (45-72) 13 (6-24) 99-100 IV & IA 1 (1-2) 0 0 NA
Bartoli, 200913 R 12 (10) 60 (49-79) 12 (5-21) 50-99 IV 8 (1-16) 0 1 1 (1-3) at 3
months
Crozier, 201014 R 10 (3) 66 (50-89)a NA >65 IV 8 (2-23) 3 0 NA
Shalhoub, 20118 R 6 (4) 69 (51-75)a NA NA IV 5.5 (4-9)b 0 0 NA
Leseche, 201215 R 7 (NA) NA 9 (5-15) >60 IV NA 0 0 NA
Rathenborg,
20127
R 22 (7) NA (52-74) NA 50-99 IV 11 (5-12)c 0 0 NA
IA, Intra-arterial; ICH, intracerebral hemorrhage; IV, intravenous; M, male; mRS, modiﬁed Rankin Scale following discharge; NA, not available; NIHSS,
National Institutes of Health Stroke Scale; P, prospective; R, retrospective.
aMedian (range).
bTiming of CEA from thrombolysis.
cMedian (interquartile range).
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Score de l’Unite Neuro-Vasculaire after thrombolysis
(median of 0, range, 0-1), which is a simpliﬁed version of
the NIHSS score at the local center.
Six studies7,10,12-15 performed intravenous thrombolysis
with rtPA, and two9,11 performed intra-arterial thromboly-
sis. Moreover, McPherson et al12 performed intra-aortic
thrombolysis with rtPA in patients with NIHSS >10 after
the initial thrombolysis. Following the initial thrombolysis,
Bartoli et al13 reported that all patients had unfractionated
heparin infusion 24 hours later until CEA, and McPherson
et al12 reported that three patients received intravenous
heparin infusion.
Patient selection criteria. Although currently there is
no general consensus on patient selection criteria for CEA
following thrombolysis, few authors have reported their
institutional protocol. Bartoli et al13 have included patients
with fully recanalized cerebral arteries, absence of hemor-
rhagic transformation or cerebral edema, stable neurologic
status, and presence of ischemic infarct inferior to one-thirdof the middle cerebral artery (MCA) territory on brain
imaging. Eckstein et al10 included all patients without cere-
bral coma and ICH. Leseche et al15 reported the contrain-
dications for early CEA in patients with major disabling
stroke (mRS >4), impaired consciousness, ischemic infarct
of one-third or more of theMCA territory on brain imaging
and hemorrhagic transformation or cerebral edema. Uno
et al11 included patients without cardiac arrhythmia or
valvular heart disease, absence of new infarct on brain
imaging, and presence of collateral circulation visualized on
cerebral angiograms.
CEA. On the timing of CEA, results for individual
patients were only available in ﬁve studies9-13 with a median
of 5 days (range, 1-54 days). Crozier et al14 reported amedian
of 8 days (range, 2-23),Rathenborgh et al7 reported amedian
of 11 days (interquartile range, 5-12) and Shalhoub et al8
reported on the timing of CEA from thrombolysis. All three
studies above did not publish the results for individual patient.
Leseche et al15 did not publish the timing of CEA in patients
who received surgery following thrombolysis.
Table IV. Summary of systematic review
Section of systematic review Outcome
Articles included d Nine articles (seven full-text articles and two conference abstracts) were included the systematic review.
d Attempts had been made to contact the corresponding authors but the response received was poor
(only two authors replied).
Preoperative management d Four studies9,12,13,15 reported on NIHSS score on admission.
d One study14 reported the median fall in NIHSS 24 hours after thrombolysis (7; range, 0-12).
d None reported on NIHSS following thrombolysis.
d Six studies7,10,12-15 performed intravenous thrombolysis.
d Two studies9,11 performed intra-arterial thrombolysis.
CEA d The median timing of CEA from the onset of ischemic stroke was 5 days (range, 1-54 days) in ﬁve
studies.9-13
d Two studies reported median of 8 days14 (range, 2-23 days) and 11 days7 (IQR, 5-12 days).
d One study8 reported a median of 5.5 days (4-9 days) from thrombolysis to CEA.
Overall 30-day postoperative
ICH
d 3% (2/77)
Overall 30-day postoperative
morbidity
d 4% (3/77)
Overall 30-day postoperative
mortality
d 0%
CEA, Carotid endarterectomy; ICH, intracerebral hemorrhage; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale.
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 6 Yong et al 1675Following CEA, only two studies reported on postoper-
ative care. Bartoli et al13 reported that caution was taken to
prevent hypertension, and rehabilitation was commenced
with gradual verticalization to prevent hemodynamic distur-
bance of the brain. Leseche et al15 maintained patients’
blood pressure #130/70 mm Hg and commenced
them with aspirin and/or clopidogrel on discharge.
Thirty-day postoperative ICH and morbidity. The
30-day postoperative morbidity was only reported by
Crozier et al14 where three patients experienced bleeding
from wound, wound hematoma, and postoperative confu-
sion, respectively, which were all resolved prior to discharge.
While assessing the methods and results section of other
manuscripts, some did not report on the presence or absence
of postoperative morbidity. We therefore assumed the lack of
reporting meant that it did not occur. Overall, one patient
(1%) in the pooled data analysis experienced postoperative
ICHwithin30days.Whenwe includeour series in the pooled
data analysis, the 30-day postoperative ICH was 3% (2/77).
There was no 30-day postoperative recurrent ischemic stroke
or mortality.
Follow-up. Endo et al9 followed-up patients at 3 to 6
months with MRI angiography, Bartoli et al13 at 3 months
with duplex ultrasound, and Leseche et al15 at 1 and 3
months with duplex ultrasound as well as CT or MRI of the
brain at 3 months. No patients had experienced recurrent
stroke until the follow-up period.
DISCUSSION
The main concern on performing CEA after thrombol-
ysis is whether the administration of thrombolytic agent, in
combination of antiplatelet therapy and early CEA increasethe risk of postoperative ICH. Although this is a small
study, it is the ﬁrst systematic review of the safety of
CEA following thrombolysis for acute ischemic stroke in
the literature. The ﬁndings of the present study revealed
a postoperative ICH of 3%, slightly higher than the re-
ported incidence of ICH in patients without thrombolysis
(0.3%-1.2%).16-23 However, the limited number of patients
and the nature of this study preclude any statistical analysis.
In a review of ICH following CEA in patients without
thrombolysis, the median duration from surgery to ICH
was 4 days (range, intraoperative to 25 days).24 It was
thought that following an ischemic infarction, there is
a critical period in which an increase in cerebral perfusion
pressure could lead to ICH adjacent to the infarct.25
Several studies have investigated the risk factors of ICH
after CEA in patients without thrombolysis. Common risk
factors that were identiﬁed include a higher degree (>90%)
of ipsilateral carotid stenosis, limited hemispheric contralat-
eral ﬂow, and hyperperfusion.21,23,24,26 Other risk factors
were younger patients,26 hypertension,26 anticoagulation
therapy,23 and perioperative ischemic event.23 In contrary,
Russell et al24 reported that patients who suffer ICH are
mostly normotensive, and it was difﬁcult to know whether
hypertension plays a role in the pathogenesis of ICH after
CEA or if it is a normal response to a sudden rise in intracra-
nial pressure. The cause of ICH is proposed to be cerebral
hyperperfusion syndrome, which can be explained by the
existence of a high grade carotid stenosis based on the
normal pressure breakthrough theory.27 Chronic cerebral
hemispheric hypoperfusion secondary to extracranial carotid
stenosis causes compensatory intracranial vasodilation and
therefore loss of autoregulation. Following CEA, normal
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hemisphere. The sudden increase of ﬂow and pressure in
the maximally dilated cerebral vasculature leads to hyper-
emia. These result in the clinical symptoms of cerebral hyper-
perfusion syndrome and may evolve into ICH when the
cerebral vessels rupture. Therefore, several authors have
advocated the prevention of postoperative hypertension
to minimize the risk of ICH.21,23,24,26 Furthermore, perio-
perative ischemic events might also increase the risk of
ICH when the fragmentation of emboli or relaxation of
vascular spasm causes the embolus to move distally. This
subsequently exposes the previously ischemic tissue to
systolic blood pressure and, hence, hemorrhages from the
injured capillaries.28
Comparing the two patients that suffered postoperative
ICH in the present study, hypertension was a common risk
factor. The patient in the Nottingham series, who had
a normal preoperative pressure, experienced intraoperative
and postoperative hypertension with a blood pressure of up
to 200/100 mm Hg and 160/70 mm Hg, respectively.
She had an ipsilateral carotid stenosis of 70%-79% and
contralateral stenosis of 60%-69%. Our unit’s protocol was
that all patients with hypertension post-CEA should be
treated initially with labetalol, follow by intravenous beta-
blocker infusion in refractory cases with close monitoring
in high dependency or intensive care unit. Despite the blood
pressure being managed with aggressive medical manage-
ment, ICH with midline shift of 3 mL was conﬁrmed on
CT of the brain the same day after CEA. The other patient
was reported by Bartoli et al13 to have a systolic blood
pressure of 180 mm Hg postoperatively. She had an ipsilat-
eral carotid stenosis of 90% without any stenosis on the
contralateral side. Initial CT angiography showed that she
had ipsilateral occlusion of the M1 segment of the MCA
and intracranial internal carotid artery. However, the extent
of ICH and the presence of midline shift were not reported.
TheEuropeanCooperativeAcute Stroke Study investigators
suggested that only parenchymal hematomas with substan-
tial space-occupying effect covering more than one-third of
the infarcted tissue volumewere associated with an increased
risk of early deterioration, disability, and death.29
In addition to the aforementioned risk factors, patient
selection is an important factor in determining surgical
outcome. Besides the apparent exclusion of disabling
stroke and ICH prior to surgery, some studies have sug-
gested that patients should have minimal evidence of
ischemic infarction on brain imaging.10,15 Three authors
have reported the ﬁndings of brain imaging9-11 as minimal
or small ischemic infarction. Nonetheless, there is no
general consensus on the deﬁnition of minimal infarction.
Furthermore, Eckstein et al9 suggested that simultaneous
occlusion of the MCA to be an important factor in patient
selection. In a study where 34 patients with acute ICA
occlusion have undergone emergency CEA, nine patients
were found to have thrombus in the MCA seen on angi-
ography. These patients either died from severe infarction
or hemorrhage, or performed poorly in postoperative
period.30The timing of CEA remains the key to successful reduc-
tion in the risk of recurrent ischemic stroke. There is robust
evidence to suggest that patients will gainmost beneﬁt when
CEA is performed within 14 days from the onset of symp-
toms.1 However, several authors7,8,10,11 have performed
CEA beyond the 14-day time frame and two studies7,8
were published before the evidence for early CEA was
published.1
There are several limitations to this study. It should be
emphasized that we are focusing on a highly selected
subgroup of patients who have received CEA following
successful thrombolysis. Furthermore, the number of
patients who received CEA after thrombolysis for acute
ischemic stroke remains small, with a reported rate of
2%-6% in the literature.11,13,14 The largest series of patients
having CEA after thrombolysis for acute ischemic stroke
was reported by Rathenborg et al7 (n ¼ 22). Secondly,
data such as the time from onset of symptoms to thrombol-
ysis, pre- and post-thrombolysis CT of the brain, pre- and
post-thrombolysis NIHSS score, the degree of ipsilateral
and contralateral stenosis, surgical technique, and mRS
from series included were only partially available. Lastly,
this is a systematic review of case series, which inevitably
suffers from methodological quality, selection, and report-
ing bias, in which postoperative morbidities may have been
under reported.
In conclusion, CEA following thrombolysis for acute
ischemic stroke appears to be safe, with a relatively low
risk of postoperative ICH. It could potentially be per-
formed according to the current guideline on CEA in
patients with minor stroke and transient ischemic attack.5
ICH after CEA following thrombolysis seems to be
a trade-off for a lower risk of recurrent ischemic stroke,
and it may never be able to be avoided entirely. A registry
would be required to reﬁne patient selection criteria and to
identify complications as well as patients who are at high
risk of postoperative ICH.
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